Long-term Use of Eculizumab for Prolonged Hemolysis Following a Delayed Hemolytic Transfusion Reaction in Pediatric Sickle Cell: A Case Report. [PDF]
Noda C, Sisler I.
europepmc +1 more source
Identification of 22 novel mutations in patients with Glanzmann's thrombasthenia [PDF]
Glanzmann's thrombasthenia (GT) is an autosomal recessive inherited platelet function defect that characterized by reduction in, or absence of, platelet aggregation in response to multiple physiologic agonists. GT is characterized by normal platelet
Abdul Ethayathulla +6 more
core +1 more source
An Unusual Case of Delayed Hemolytic Transfusion Reaction With Hyperhemolysis Syndrome Due to Anti-Jkb and Anti-Fya Alloantibodies. [PDF]
El Alaoui K, Benghiat FS, Colard M.
europepmc +1 more source
Severe Acute Hemolytic Transfusion Reaction Treated with Ruxolitinib and Plasma Exchange. [PDF]
Deveci B +5 more
europepmc +1 more source
Utilizing Blood Bank Resources/Transfusion Reactions and Complications
Abdul‐Kader Souid +2 more
openalex +1 more source
Life‐threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab [PDF]
Mark Boonyasampant +5 more
openalex +1 more source
Prevention of non-hemolytic blood transfusion reaction by cleaning blood platelets.
NOBUYUKI MOMONA
openalex +2 more sources
Delayed hemolytic transfusion reaction associated with anti-Au<sup>a</sup> antibody in a young male with beta-thalassemia. [PDF]
Luniewski A +3 more
europepmc +1 more source
Relationship between Bacterial Load, Species Virulence, and Transfusion Reaction with Transfusion of Bacterially Contaminated Platelets [PDF]
Michael R. Jacobs +3 more
openalex +1 more source

